Brief: Rencofilstat Produces Positive Outcomes In Translational Study On Idiopathic Pulmonary Fibrosis
14/09/2023 13:48
Sept 14 (Reuters) - Hepion Pharmaceuticals Inc HEPA.O :
* RENCOFILSTAT PRODUCES POSITIVE OUTCOMES IN TRANSLATIONAL
STUDY
ON IDIOPATHIC PULMONARY FIBROSIS
Source text for Eikon: ID:nGNX4mTGYV
Further company coverage: HEPA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Hepion Pharmaceuticals
See all newsBrief: Hepion Pharmaceuticals Executes Binding Letter Of Intent With New Day Diagnostics To Commercialize Diagnostic Tests For Celiac Disease, Respiratory Multiplex, H. Pylori And Hcc
Brief: Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing
Brief: Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B
Brief: Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Brief: Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement